A drug Interaction study to assess the pharmacokinetics of a potent HCV protease inhibitor narlaprevir and antiretroviral drugs

Authors
Category Primary study
ConferenceHepatology International
Year 2018
This article has no abstract
Epistemonikos ID: 814a3cc21cf6d9a5a46503f9506375581d4a3d86
First added on: Apr 29, 2026